Related references
Note: Only part of the references are listed.MALAT1 long non-coding RNA and breast cancer
Gayatri Arun et al.
RNA BIOLOGY (2019)
Disturbed Flow Increases UBE2C (Ubiquitin E2 Ligase C) via Loss of miR-483-3p, Inducing Aortic Valve Calcification by the pVHL (von Hippel-Lindau Protein) and HIF-1 (Hypoxia-Inducible Factor-1) Pathway in Endothelial Cells
Joan Fernandez Esmerats et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway
Miao-Miao Li et al.
LIFE SCIENCES (2019)
UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells
Yan Wu et al.
JOURNAL OF ONCOLOGY (2019)
Emerging roles of long non-coding RNA in cancer
Anna Sanchez Calle et al.
CANCER SCIENCE (2018)
The role of long noncoding RNAs in cancer: the dark matter matters
Xiaowen Hu et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Noncoding RNA:RNA Regulatory Networks in Cancer
Jia Jia Chan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer
Yating Cheng et al.
PLOS ONE (2018)
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
Jiwei Guo et al.
ONCOGENESIS (2018)
被撤回的出版物: The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells (Retracted article. See vol. 63, 2021)
Jiwei Guo et al.
EBIOMEDICINE (2018)
MALATI induces tongue cancer cells' EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway
Jun Liang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2017)
Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer
Hu YiRen et al.
MOLECULAR CANCER (2017)
miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer
Ruifang Sun et al.
CELL DEATH & DISEASE (2017)
MALAT1 Modulates TGF-beta 1 nduced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145
Yin Xiang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Long non-coding RNA Malat1 promotes neurite outgrowth through activation of ERK/MAPK signalling pathway in N2a cells
Lei Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer
Zeng Hui et al.
FEBS LETTERS (2015)
MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway
Yongqiang Dong et al.
TUMOR BIOLOGY (2015)
Long Noncoding RNAs: Insights from Biological Features and Functions to Diseases
Xiaolei Li et al.
MEDICINAL RESEARCH REVIEWS (2013)
Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker
Zhonglin Hao et al.
TUMOR BIOLOGY (2012)
The functional role of long non-coding RNA in human carcinomas
Ewan A. Gibb et al.
MOLECULAR CANCER (2011)
Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation
Janine H. van Ree et al.
JOURNAL OF CELL BIOLOGY (2010)
Evolution and Functions of Long Noncoding RNAs
Chris P. Ponting et al.
CELL (2009)
Building ubiquitin chains: E2 enzymes at work
Yihong Ye et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
P Ji et al.
ONCOGENE (2003)
Share Paper
